Announced
Completed
OPEN MONOCLONAL TECHNOLOGY INC / LIGAND PHARMACEUTICALS INC / ESSEX WOODLANDS HEALTH VENTURES / Acquisition / Private
Synopsis
Acquisition by Ligand Pharmaceuticals of Open Monoclonal Technology, a biotechnology company engaged in genetic engineering of animals for the generation of human therapeutic antibodies.
Show Details & Financials
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.